draw the Honourable Member's attention to the fact that the Commission is currently examining, in the context of ongoing infringement proceedings, a Danish case concerning a refusal to reimburse the cost of medicinal products purchased abroad. The issue of the language requirement for bills submitted for reimbursement purposes will therefore be examined in that connection.